نتائج البحث - "G. Villacampa"

1

Patritumab Deruxtecan in Untreated Hormone Receptor–Positive/HER2-Negative Early Breast Cancer: Final Results from Part A of the Window-of-Opportunity SOLTI TOT-HER3 Pre-Operative Study

المصدر: Annals of Oncology.

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::45cedf218aa6e303442743c2ee952cca
https://doi.org/10.1016/j.annonc.2023.05.004

2

Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments

المؤلفون: J. Ros, J. Matito, G. Villacampa, R. Comas, A. Garcia, G. Martini, I. Baraibar, N. Saoudi, F. Salvà, Á. Martin, M. Antista, R. Toledo, E. Martinelli, F. Pietrantonio, A. Boccaccino, C. Cremolini, R. Dientsmann, J. Tabernero, A. Vivancos, E. Elez

المساهمون: Ros, J, Matito, J, Villacampa, G, Comas, R, Garcia, A, Martini, G, Baraibar, I, Saoudi, N, Salvà, F, Martin, Á, Antista, M, Toledo, R, Martinelli, E, Pietrantonio, F, Boccaccino, A, Cremolini, C, Dientsmann, R, Tabernero, J, Vivancos, A, Elez, E, Institut Català de la Salut, [Ros J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Matito J, Comas R, Garcia A, Toledo R, Dientsmann R, Vivancos A] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Villacampa G] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. The Institute of Cancer Research, London, UK. [Martini G] Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. [Baraibar I, Saoudi N, Salvà F, Tabernero J, Elez E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Martin Á] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: BRAF inhibitor, MEK inhibitor, Recte - Càncer - Aspectes genètics, Prognosi, Otros calificadores::Otros calificadores::/genética [Otros calificadores], Genetic Phenomena::Genetic Variation::Mutation [PHENOMENA AND PROCESSES], Còlon - Càncer - Aspectes genètics, colorectal cancer, Hematology, fenómenos genéticos::estructuras genéticas::genoma::componentes genómicos::genes::alelos [FENÓMENOS Y PROCESOS], neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales [ENFERMEDADES], anti-EGFR, mutant allele fraction, Anomalies cromosòmiques, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [DISEASES], Oncology, Other subheadings::Other subheadings::/genetics [Other subheadings], BRAF-V600E mutation, Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Alleles [PHENOMENA AND PROCESSES], Diagnosis::Prognosis [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], diagnóstico::pronóstico [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], fenómenos genéticos::variación genética::mutación [FENÓMENOS Y PROCESOS]